The IN VIVO Blog Podcast: All FDA Edition

Mike and Ramsey make another stab at Three Things in Three Minutes. Running time ... about 8 minutes.

How will new FDA leadership impact the drug industry? What's the story with the Hamburg-Sharfstein tag-team deal? Will a renewed emphasis on food safety split the agency? Will there be a bonus topic? (Of course there will ...) Just click on the IVBP logo below to get started...

Don't forget, you can access the podcast via iTunes also.

The IN VIVO Blog Podcast: Lets Make a Deal!

You'll never guess what our intrepid podcasters are talking about this week. Give up? OK we'll spill the beans: the Merck/Schering-Plough deal! We kid you not. Buckle your seatbelt and click on the logo below, and you're away.

Don't forget, you can access the podcast via iTunes also.

The IN VIVO Blog Podcast: Thoughts on Pfizer-Wyeth

Why is Pfizer buying Wyeth? Will the Big Pharma of the future look like General Electric? Is there a good reason to relocate to Indiana? Answers to all these questions and more on this week's installment of The IN VIVO Blog Podcast.

Just click the image below to get started. Oh, and we're on iTunes now as well, so please subscribe to that (it's free).

The IN VIVO Blog Podcast: Comparative Effectiveness, HHS Candidates, and Health Reform

Welcome to the first IN VIVO Blog podcast. We know ... it took us a while, but we finally got there. There will be many different kinds of podcasts from various reporters and editors of the IN VIVO Blog, which includes writers of The RPM Report, IN VIVO, The Pink Sheet, Start-Up and other publications.

Our first podcast comes to you from the editors of The RPM Report. It's called "3 things in 3 minutes." What is it? It's just that: 3 topics that we try and discuss in 3 minutes (we went a little over).

The topics for this discussion? Comparative effectiveness, the next HHS Secretary, and whether Medicare Part D should be a model for health care reform. If you listen closely, you may even be rewarded with a "bonus topic."

Click here to listen to the podcast.

So tell us what you think. We'd love to hear your thoughts. Just be gentle.